You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海凱寶(300039.SZ)及子公司取得3項實用新型專利證書
格隆匯 12-12 20:50

格隆匯12月12日丨上海凱寶(300039.SZ)公佈,公司及上海凱寶健康科技有限公司(“凱寶健康”)於近日收到國家知識產權局頒發的實用新型專利證書,涉球形濃縮器、單效濃縮器、藥物提取裝置。

球形濃縮器通過在球形罐體中設置感應式液位探測器,以接收足夠的探測數據供後台處理器進行處理,最終通過後台處理器的分析處理得出藥液液位的高度,經過大量數據的處理得到的藥液液位的高度數值精確。

單效濃縮器通過收集腔的設置,使得藥液可以實現二次或多次加熱,有效提高單效濃縮器的工作效率。並且通過帶有斜度的錐形部的設置,高效避免了藥液殘渣等物質在加熱濃縮過程中容易粘連在加熱罐內壁上的問題。

藥物提取裝置通過該裝置在腔體的內側壁、底部均設置過濾網,在藥液加熱時產生的氣泡、藥渣等物質通過側壁漏網的過濾,大幅度減少了直接朝向底部濾網的藥渣數量,有效解決了由於氣泡、藥渣等混合物較多而堵塞出液口的問題。

上述實用新型專利的取得,目前對公司及子公司的生產經營不會產生重大影響,將有利於公司及子公司進一步充分發揮自主知識產權優勢,完善知識產權保護體系,提升品牌的認知度和核心競爭力,促進公司的長遠發展

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account